Your browser doesn't support javascript.
loading
Low tumor glutathione level as a sensitivity marker for glutamate-cysteine ligase inhibitors.
Nishizawa, Satoru; Araki, Hideo; Ishikawa, Yoshinori; Kitazawa, Satoshi; Hata, Akito; Soga, Tomoyoshi; Hara, Takahito.
Afiliação
  • Nishizawa S; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Araki H; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Ishikawa Y; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Kitazawa S; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Hata A; Biomolecular Research Laboratories, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
  • Soga T; Institute for Advanced Bioscience, Keio University, Tsuruoka, Yamagata 997-0052, Japan.
  • Hara T; Oncology Drug Discovery Unit, Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, Fujisawa, Kanagawa 251-8555, Japan.
Oncol Lett ; 15(6): 8735-8743, 2018 Jun.
Article em En | MEDLINE | ID: mdl-29928324

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Japão